More on 'universal'versus'selected' screening for thrombophilia: the hidden costs of false-positive diagnosis.
Favaloro
Emmanuel J
EJ
D003362:Cost-Benefit Analysis; D005189:False Positive Reactions; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D019851:Thrombophilia / Q000175:diagnosis*